Medical management of hepatorenal syndrome
Andrew Davenport, Jawad Ahmad, Ali Al-Khafaji, John A Kellum, Yuri S Genyk, Mitra K Nadim
Nephrology, Dialysis, Transplantation 2012, 27 (1): 34-41
22287700
Hepatorenal syndrome (HRS) is defined as the occurrence of renal dysfunction in a patient with end-stage liver cirrhosis in the absence of another identifiable cause of renal failure. The prognosis of HRS remains poor, with a median survival without liver transplantation of <6 months. However, understanding the pathogenesis of HRS has led to the introduction of treatments designed to increase renal perfusion and mean arterial blood pressure using vasopressors and albumin, which has led to improvement in renal function in ∼50% of patients.
Comments
Related Papers
Raúl Valdés wrote:
The paper mentions albumin at 1 gr/kg, up to 100 gr a day for one day, then describes the same dosage for two days in a row. Which one is the better one?
Posted 15 Oct, 2014 at 23:52 |Omar Soler wrote:
Any further info on paracentesis, how much and when tomstop, also related with albumin administration.
Posted 4 Jun, 2014 at 0:59 |Nice paper!
Hass Beeb wrote:
Excellent review
Posted 21 Mar, 2014 at 12:06 |Tito Freire wrote:
Excellent review thanks you
Posted 7 Oct, 2015 at 8:22 |Alejo Ramírez wrote:
Good review, congratulaciones
Posted 27 Mar, 2015 at 11:51 |Kayak Masajes wrote:
Interesante
Posted 24 Apr, 2015 at 23:25 |Saqib Musharaf wrote:
A good study.
Posted 19 Apr, 2015 at 18:39 |Roilan Garcia wrote:
Exellent update.
Posted 9 Jan, 2015 at 16:54 |Bizimana Jean Baptiste wrote:
Good interesting
Posted 9 Dec, 2018 at 10:45 |Abdullah Asiri wrote:
Nice
Posted 19 Apr, 2017 at 23:33 |lorena teresita wrote:
Good
Posted 26 Sep, 2016 at 23:44 |FABIANA contieri wrote:
Very Nice review!
Posted 25 Mar, 2016 at 20:12 |Dr.Abhinav Choudhury wrote:
Helpful
Posted 23 Nov, 2015 at 6:13 |